Pembrolizumab vs Propranolol
Pembrolizumab vs Propranolol: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Propranolol.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Propranolol: Non-selective beta-adrenergic receptor blocker.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Propranolol — 3-6 hours.
Chemical Properties
Molecular Formula: Propranolol — C16H21NO2.
Molecular Weight: Propranolol — 259.3440 g/mol.
Type: Pembrolizumab — Antibody; Propranolol — Small molecule.